NESS ZIONA, Israel, November 5, 2025 — Leads & Copy — BiomX Inc. (NYSE American: PHGE) will report its third quarter 2025 financial results and program updates before the U.S. financial markets open on Wednesday, November 12, 2025. A conference call and live audio webcast will be hosted at 8:30 a.m. ET to discuss the results and provide updates.
To connect before the call, BiomX suggests registering at least 5 minutes prior. Those not planning to ask questions are recommended to listen via webcast.
Conference Call Dial-In: https://register-conf.media-server.com/register/BIf7434533b852452a822a8e5f48b669e2
Webcast: https://edge.media-server.com/mmc/p/s6tntmgo
The live and archived webcast will also be available in the Investors section of the Company’s website.
BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (“BacteriOphage Lead to Treatment”) platform to customize phage compositions against these targets.
Contacts:
BiomX, Inc.
Ben Cohen
Head Corporate Communications
benc@biomx.com
Source: BiomX Inc.
